TY - JOUR AU - Curatolo, P. AU - Bombardieri, R. AU - Jozwiak, S. PY - 2008 DA - 2008// TI - Tuberous sclerosis JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61279-9 DO - 10.1016/S0140-6736(08)61279-9 ID - Curatolo2008 ER - TY - JOUR AU - Curatolo, P. AU - Moavero, R. AU - Vries, P. J. PY - 2015 DA - 2015// TI - Neurological and neuropsychiatric aspects of tuberous sclerosis complex JO - Lancet Neurol VL - 14 UR - https://doi.org/10.1016/S1474-4422(15)00069-1 DO - 10.1016/S1474-4422(15)00069-1 ID - Curatolo2015 ER - TY - JOUR AU - Chu-Shore, C. J. AU - Major, P. AU - Camposano, S. AU - Muzykewicz, D. AU - Thiele, E. A. PY - 2010 DA - 2010// TI - The natural history of epilepsy in tuberous sclerosis complex JO - Epilepsia VL - 51 UR - https://doi.org/10.1111/j.1528-1167.2009.02474.x DO - 10.1111/j.1528-1167.2009.02474.x ID - Chu-Shore2010 ER - TY - JOUR AU - Krueger, D. A. AU - Northrup, H. PY - 2013 DA - 2013// TI - Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference JO - Pediatr Neurol VL - 49 UR - https://doi.org/10.1016/j.pediatrneurol.2013.08.002 DO - 10.1016/j.pediatrneurol.2013.08.002 ID - Krueger2013 ER - TY - JOUR AU - Vries, P. J. AU - Whittemore, V. H. AU - Leclezio, L. AU - Byars, A. W. AU - Dunn, D. AU - Ess, K. C. PY - 2015 DA - 2015// TI - Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist JO - Pediatr Neurol VL - 52 UR - https://doi.org/10.1016/j.pediatrneurol.2014.10.004 DO - 10.1016/j.pediatrneurol.2014.10.004 ID - Vries2015 ER - TY - JOUR AU - Kingswood, J. C. AU - d’Augères, G. B. AU - Belousova, E. AU - Ferreira, J. C. AU - Carter, T. AU - Castellana, R. PY - 2017 DA - 2017// TI - TuberOus SClerosis registry to increase disease Awareness (TOSCA)—baseline data on 2093 patients JO - Orphanet Journal of Rare Diseases VL - 12 UR - https://doi.org/10.1186/s13023-016-0553-5 DO - 10.1186/s13023-016-0553-5 ID - Kingswood2017 ER - TY - JOUR AU - Vries, P. J. PY - 2010 DA - 2010// TI - Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex JO - Neurotherapeutics VL - 7 UR - https://doi.org/10.1016/j.nurt.2010.05.001 DO - 10.1016/j.nurt.2010.05.001 ID - Vries2010 ER - TY - JOUR AU - Randell, E. AU - McNamara, R. AU - Davies, D. M. AU - Owen-Jones, E. AU - Kirby, N. AU - Angel, L. PY - 2016 DA - 2016// TI - The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial JO - Trials VL - 17 UR - https://doi.org/10.1186/s13063-016-1446-6 DO - 10.1186/s13063-016-1446-6 ID - Randell2016 ER - TY - JOUR AU - Krueger, D. A. AU - Sadhwani, A. AU - Byars, A. W. AU - Vries, P. J. AU - Franz, D. N. AU - Whittemore, V. H. PY - 2017 DA - 2017// TI - Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders JO - Ann Clin Transl Neurol VL - 4 UR - https://doi.org/10.1002/acn3.494 DO - 10.1002/acn3.494 ID - Krueger2017 ER - TY - STD TI - Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, et al. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. 2019. ID - ref10 ER - TY - JOUR AU - Talos, D. M. AU - Sun, H. AU - Kosaras, B. AU - Joseph, A. AU - Folkerth, R. D. AU - Poduri, A. PY - 2012 DA - 2012// TI - Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia JO - Ann Neurol VL - 71 UR - https://doi.org/10.1002/ana.22696 DO - 10.1002/ana.22696 ID - Talos2012 ER - TY - JOUR AU - Ben-Ari, Y. PY - 2017 DA - 2017// TI - NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders JO - Trends Neurosci VL - 40 UR - https://doi.org/10.1016/j.tins.2017.07.001 DO - 10.1016/j.tins.2017.07.001 ID - Ben-Ari2017 ER - TY - JOUR AU - Ruffolo, G. AU - Iyer, A. AU - Cifelli, P. AU - Roseti, C. AU - Muhlebner, A. AU - Scheppingen, J. PY - 2016 DA - 2016// TI - Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions JO - Neurobiol Dis VL - 95 UR - https://doi.org/10.1016/j.nbd.2016.07.014 DO - 10.1016/j.nbd.2016.07.014 ID - Ruffolo2016 ER - TY - JOUR AU - Loscher, W. AU - Puskarjov, M. AU - Kaila, K. PY - 2013 DA - 2013// TI - Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments JO - Neuropharmacology. VL - 69 UR - https://doi.org/10.1016/j.neuropharm.2012.05.045 DO - 10.1016/j.neuropharm.2012.05.045 ID - Loscher2013 ER - TY - JOUR AU - Lozovaya, N. AU - Gataullina, S. AU - Tsintsadze, T. AU - Tsintsadze, V. AU - Pallesi-Pocachard, E. AU - Minlebaev, M. PY - 2014 DA - 2014// TI - Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model JO - Nature Commun VL - 5 UR - https://doi.org/10.1038/ncomms5563 DO - 10.1038/ncomms5563 ID - Lozovaya2014 ER - TY - JOUR AU - Kharod, S. C. AU - Kang, S. K. AU - Kadam, S. D. PY - 2019 DA - 2019// TI - Off-Label use of bumetanide for brain disorders: an overview JO - Front Neurosci VL - 13 UR - https://doi.org/10.3389/fnins.2019.00310 DO - 10.3389/fnins.2019.00310 ID - Kharod2019 ER - TY - JOUR AU - Schulte, J. T. AU - Wierenga, C. J. AU - Bruining, H. PY - 2018 DA - 2018// TI - Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions JO - Neurosci Biobehav Rev VL - 90 UR - https://doi.org/10.1016/j.neubiorev.2018.05.001 DO - 10.1016/j.neubiorev.2018.05.001 ID - Schulte2018 ER - TY - JOUR AU - Eftekhari, S. AU - Mehvari Habibabadi, J. AU - Najafi Ziarani, M. AU - Hashemi Fesharaki, S. S. AU - Gharakhani, M. AU - Mostafavi, H. PY - 2013 DA - 2013// TI - Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy JO - Epilepsia VL - 54 UR - https://doi.org/10.1111/j.1528-1167.2012.03654.x DO - 10.1111/j.1528-1167.2012.03654.x ID - Eftekhari2013 ER - TY - JOUR AU - Kahle, K. T. AU - Barnett, S. M. AU - Sassower, K. C. AU - Staley, K. J. PY - 2009 DA - 2009// TI - Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1 JO - J Child Neurol VL - 24 UR - https://doi.org/10.1177/0883073809333526 DO - 10.1177/0883073809333526 ID - Kahle2009 ER - TY - JOUR AU - Northrup, H. AU - Krueger, D. A. PY - 2013 DA - 2013// TI - International Tuberous Sclerosis Complex Consensus G. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference JO - Pediatr Neurol VL - 49 UR - https://doi.org/10.1016/j.pediatrneurol.2013.08.001 DO - 10.1016/j.pediatrneurol.2013.08.001 ID - Northrup2013 ER - TY - JOUR AU - Lemonnier, E. AU - Villeneuve, N. AU - Sonie, S. AU - Serret, S. AU - Rosier, A. AU - Roue, M. PY - 2017 DA - 2017// TI - Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders JO - Transl Psychiatry VL - 7 UR - https://doi.org/10.1038/tp.2017.101 DO - 10.1038/tp.2017.101 ID - Lemonnier2017 ER - TY - JOUR AU - Aman, M. G. AU - Singh, N. N. AU - Stewart, A. W. AU - Field, C. J. PY - 1985 DA - 1985// TI - The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects JO - Am J Mental Deficiency VL - 89 ID - Aman1985 ER - TY - JOUR AU - Constantino, J. N. AU - Davis, S. A. AU - Todd, R. D. AU - Schindler, M. K. AU - Gross, M. M. AU - Brophy, S. L. PY - 2003 DA - 2003// TI - Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised JO - J Autism Dev Disord VL - 33 UR - https://doi.org/10.1023/A:1025014929212 DO - 10.1023/A:1025014929212 ID - Constantino2003 ER - TY - BOOK AU - Dunn, W. PY - 1999 DA - 1999// TI - Sensory profile: User's manual: Psychological Corporation San Antonio, TX ID - Dunn1999 ER - TY - BOOK AU - Dunn, W. PY - 2006 DA - 2006// TI - Sensory profile-school companion manual PB - Psychological Corporation CY - San Antonio, TX ID - Dunn2006 ER - TY - JOUR AU - Lam, K. S. AU - Aman, M. G. PY - 2007 DA - 2007// TI - The Repetitive behavior scale-revised: independent validation in individuals with autism spectrum disorders JO - J Autism Dev Disord VL - 37 UR - https://doi.org/10.1007/s10803-006-0213-z DO - 10.1007/s10803-006-0213-z ID - Lam2007 ER - TY - BOOK AU - Gioia, G. A. AU - Isquith, P. K. AU - Guy, S. C. AU - Kenworthy, L. PY - 2015 DA - 2015// TI - BRIEF-2: Behavior rating inventory of executive function: professional manual: psychological assessment resources ID - Gioia2015 ER - TY - JOUR PY - 1998 DA - 1998// TI - Development of the World Health Organization WHOQOL-BREF quality of life assessment JO - Psychological medicine. VL - 28 UR - https://doi.org/10.1017/S0033291798006667 DO - 10.1017/S0033291798006667 ID - ref28 ER - TY - JOUR AU - Herdman, M. AU - Gudex, C. AU - Lloyd, A. AU - Janssen, M. AU - Kind, P. AU - Parkin, D. PY - 2011 DA - 2011// TI - Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5 L) JO - Qual Life Res VL - 20 UR - https://doi.org/10.1007/s11136-011-9903-x DO - 10.1007/s11136-011-9903-x ID - Herdman2011 ER - TY - JOUR AU - Wille, N. AU - Badia, X. AU - Bonsel, G. AU - Burström, K. AU - Cavrini, G. AU - Devlin, N. PY - 2010 DA - 2010// TI - Development of the EQ-5D-Y: a child-friendly version of the EQ-5D JO - Qual Life Res VL - 19 UR - https://doi.org/10.1007/s11136-010-9648-y DO - 10.1007/s11136-010-9648-y ID - Wille2010 ER - TY - JOUR AU - Varni, J. W. AU - Seid, M. AU - Kurtin, P. S. PY - 2001 DA - 2001// TI - PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations JO - Medical Care VL - 39 UR - https://doi.org/10.1097/00005650-200108000-00006 DO - 10.1097/00005650-200108000-00006 ID - Varni2001 ER - TY - JOUR AU - Vlaskamp, C. AU - Oranje, B. AU - Madsen, G. F. AU - Møllegaard Jepsen, J. R. AU - Durston, S. AU - Cantio, C. PY - 2017 DA - 2017// TI - Auditory processing in autism spectrum disorder: Mismatch negativity deficits JO - Autism Res VL - 10 UR - https://doi.org/10.1002/aur.1821 DO - 10.1002/aur.1821 ID - Vlaskamp2017 ER - TY - JOUR AU - Madsen, G. F. AU - Bilenberg, N. AU - Cantio, C. AU - Oranje, B. PY - 2014 DA - 2014// TI - Increased prepulse inhibition and sensitization of the startle reflex in autistic children JO - Autism Res VL - 7 UR - https://doi.org/10.1002/aur.1337 DO - 10.1002/aur.1337 ID - Madsen2014 ER - TY - STD TI - Madsen GF, Bilenberg N, Jepsen JR, Glenthoj B, Cantio C, Oranje B. Normal P50 Gating in Children with Autism, Yet Attenuated P50 Amplitude in the Asperger Subcategory. 2015 (1939-3806 (Electronic)). ID - ref34 ER - TY - JOUR AU - Vries, P. AU - Humphrey, A. AU - McCartney, D. AU - Prather, P. AU - Bolton, P. AU - Hunt, A. PY - 2005 DA - 2005// TI - Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis JO - Eur Child Adolesc Psychiatry VL - 14 UR - https://doi.org/10.1007/s00787-005-0443-1 DO - 10.1007/s00787-005-0443-1 ID - Vries2005 ER - TY - JOUR AU - Sonneville, L. PY - 1999 DA - 1999// TI - Amsterdam Neuropsychological tasks: a computer-aided assessment program JO - Cognitive Ergonomics, Clinical Assessment and Computer-assisted Learning: Computers in Psychology. VL - 6 ID - Sonneville1999 ER - TY - BOOK AU - Cohen, J. PY - 1988 DA - 1988// TI - Statistical power analysis for the behavioral sciences: Routledge ID - Cohen1988 ER - TY - JOUR AU - Lemonnier, E. AU - Ben-Ari, Y. PY - 2010 DA - 2010// TI - The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects JO - Acta Paediatr VL - 99 UR - https://doi.org/10.1111/j.1651-2227.2010.01933.x DO - 10.1111/j.1651-2227.2010.01933.x ID - Lemonnier2010 ER - TY - JOUR AU - Lemonnier, E. AU - Degrez, C. AU - Phelep, M. AU - Tyzio, R. AU - Josse, F. AU - Grandgeorge, M. PY - 2012 DA - 2012// TI - A randomised controlled trial of bumetanide in the treatment of autism in children JO - Transl Psychiatry VL - 2 UR - https://doi.org/10.1038/tp.2012.124 DO - 10.1038/tp.2012.124 ID - Lemonnier2012 ER - TY - JOUR AU - Miyajima, M. AU - Ohta, K. AU - Hara, K. AU - Iino, H. AU - Maehara, T. AU - Hara, M. PY - 2011 DA - 2011// TI - Abnormal mismatch negativity for pure-tone sounds in temporal lobe epilepsy JO - Epilepsy Res VL - 94 UR - https://doi.org/10.1016/j.eplepsyres.2011.01.009 DO - 10.1016/j.eplepsyres.2011.01.009 ID - Miyajima2011 ER - TY - JOUR AU - Lopes, R. AU - Simões, M. R. AU - Ferraz, L. AU - Leal, A. J. R. PY - 2014 DA - 2014// TI - The mismatch negativity (MMN) potential as a tool for the functional mapping of temporal lobe epilepsies JO - Epilepsy Behav VL - 33 UR - https://doi.org/10.1016/j.yebeh.2014.02.017 DO - 10.1016/j.yebeh.2014.02.017 ID - Lopes2014 ER - TY - JOUR AU - Vries, P. J. AU - Franz, D. N. AU - Curatolo, P. AU - Nabbout, R. AU - Neary, M. AU - Herbst, F. PY - 2018 DA - 2018// TI - Measuring Health-related quality of life in tuberous sclerosis complex—psychometric evaluation of three instruments in individuals with refractory epilepsy JO - Front Pharmacol VL - 9 UR - https://doi.org/10.3389/fphar.2018.00964 DO - 10.3389/fphar.2018.00964 ID - Vries2018 ER - TY - STD TI - Kharod SC, Kang SK, Kadam SD. Off-Label Use of Bumetanide for Brain Disorders: An Overview. Frontiers in neuroscience. 2019;13:310-. ID - ref43 ER - TY - STD TI - Stunnenberg BC, Raaphorst J, Groenewoud HM, Statland JM, Griggs RC, Woertman W, et al. Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials. (1538-3598 (Electronic)). https://doi.org/10.1001/jama.2018.18020. ID - ref44 ER -